Clinical Trials Logo
  1. Home
  2. Alcohol-Related Disorders
  3. NCT00402571

Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics

Alcohol Related Disorders Clinical Trial

Official title:
Assessment of Hepatic Function in Alcoholic Patients Administered Therapeutic Dosing of Acetaminophen- a Multicenter Study

Clinical Trial Summary

The study objective was to determine whether liver injury develops in alcoholic patients who ingest therapeutic doses of APAP for three consecutive days. Volunteers were recruited from two community detoxification centers to take either acetaminophen (4 g/day) or placebo for 3 consecutive days and remain in the facility an additional 2 days for monitoring. The primary measures were aminotransferase measures taken at baseline and Days 2-5. We hypothesized that there would be no difference in aminotransferase measures between the acetaminophen and placebo study groups.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Double-Blind

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00402571
Study type Interventional
Source Denver Health and Hospital Authority
Contact
Status Completed
Phase Phase 4
Start date January 2002
Completion date July 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT01544218 - Validating NIAAA Screen Guide in YCMC N/A
Withdrawn NCT01539954 - Computerized Alcohol Screening for Children and Adolescents N/A
Active, not recruiting NCT01655615 - Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction? N/A
Completed NCT00202514 - Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms Phase 2/Phase 3
Completed NCT00427206 - Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing Phase 4
Completed NCT00132262 - Brief Intervention to Reduce Injury in Minorities N/A
Completed NCT02407340 - Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder Phase 1
Completed NCT00734656 - Pharmacogenetics of Alcohol: Treatment Implications N/A
Completed NCT00379093 - Healthy Living as You Age Phase 2
Completed NCT00802321 - Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects N/A